Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

Conditions:   Aggressive Non-Hodgkin Lymphoma;   Indolent Non-Hodgkin Lymphoma;   Recurrent Adult Non-Hodgkin Lymphoma;   Recurrent Diffuse Large B-Cell Lymphoma;   Recurrent Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Medias tinal (Thymic) Large B-Cell Cell Lymphoma;   Recurrent T-Cell Non-Hodgkin Lymphoma;   Small Lymphocytic Lymphoma Interventions:   Procedure: Cryosurgery;   Biological: Dendritic Cell Therapy;   Biological: Pembrolizumab;   Biological: Pneumococcal 13-valent Conjugate Vaccine;   Other: Quality-of-Life Assessment Sponsors:   Mayo Clinic;   National Cancer Institute (NCI) Not yet recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials